CLINICAL_TRIALS
trial_result
· 2025-06-05
Clinical Trial Update: Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008) [Phase 1]
Summary
A Phase 1 multiple rising dose study of MK-6194 in participants with atopic dermatitis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED | Results posted: 2025-06-05